|
Name |
Citronellyl anthranilate
|
| Molecular Formula | C17H25NO2 | |
| IUPAC Name* |
3,7-dimethyloct-6-enyl 2-aminobenzoate
|
|
| SMILES |
CC(CCC=C(C)C)CCOC(=O)C1=CC=CC=C1N
|
|
| InChI |
InChI=1S/C17H25NO2/c1-13(2)7-6-8-14(3)11-12-20-17(19)15-9-4-5-10-16(15)18/h4-5,7,9-10,14H,6,8,11-12,18H2,1-3H3
|
|
| InChIKey |
LSJVFMHIFWWGDY-UHFFFAOYSA-N
|
|
| Synonyms |
Citronellyl anthranilate; 3,7-Dimethyloct-6-enyl 2-aminobenzoate; 68555-57-7; 6-Octen-1-ol, 3,7-dimethyl-, 2-aminobenzoate; 6-Octen-1-ol, 3,7-dimethyl-, 1-(2-aminobenzoate); 3,7-Dimethyl-6-octen-1-ol-2-aminobenzoate; 151MU54E8I; UNII-151MU54E8I; 3,7-dimethyloct-6-en-1-yl 2-aminobenzoate; EINECS 271-433-2; CITRONELLYLANTHRANILATE; SCHEMBL2419517; FEMA NO. 4086; DTXSID40867674; CHEBI:172321; CITRONELLYL ANTHRANILATE [FHFI]; 3,7-Dimethyl-6-octenyl 2-aminobenzoate #; 2-Aminobenzoic acid 3,7-dimethyl-6-octenyl ester; Q27251666
|
|
| CAS | 68555-57-7 | |
| PubChem CID | 109467 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 275.4 | ALogp: | 5.9 |
| HBD: | 1 | HBA: | 3 |
| Rotatable Bonds: | 8 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 52.3 | Aromatic Rings: | 1 |
| Heavy Atoms: | 20 | QED Weighted: | 0.443 |
| Caco-2 Permeability: | -4.439 | MDCK Permeability: | 0.00002620 |
| Pgp-inhibitor: | 0.016 | Pgp-substrate: | 0.008 |
| Human Intestinal Absorption (HIA): | 0.002 | 20% Bioavailability (F20%): | 0.084 |
| 30% Bioavailability (F30%): | 0.095 |
| Blood-Brain-Barrier Penetration (BBB): | 0.385 | Plasma Protein Binding (PPB): | 96.87% |
| Volume Distribution (VD): | 2.359 | Fu: | 3.51% |
| CYP1A2-inhibitor: | 0.964 | CYP1A2-substrate: | 0.297 |
| CYP2C19-inhibitor: | 0.943 | CYP2C19-substrate: | 0.27 |
| CYP2C9-inhibitor: | 0.853 | CYP2C9-substrate: | 0.565 |
| CYP2D6-inhibitor: | 0.581 | CYP2D6-substrate: | 0.511 |
| CYP3A4-inhibitor: | 0.768 | CYP3A4-substrate: | 0.16 |
| Clearance (CL): | 12.941 | Half-life (T1/2): | 0.075 |
| hERG Blockers: | 0.044 | Human Hepatotoxicity (H-HT): | 0.213 |
| Drug-inuced Liver Injury (DILI): | 0.132 | AMES Toxicity: | 0.01 |
| Rat Oral Acute Toxicity: | 0.012 | Maximum Recommended Daily Dose: | 0.035 |
| Skin Sensitization: | 0.879 | Carcinogencity: | 0.195 |
| Eye Corrosion: | 0.028 | Eye Irritation: | 0.979 |
| Respiratory Toxicity: | 0.505 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC000319 | ![]() |
0.533 | D07NAJ | ![]() |
0.316 | ||
| ENC000160 | ![]() |
0.492 | D0TZ1G | ![]() |
0.308 | ||
| ENC001800 | ![]() |
0.488 | D0GY5Z | ![]() |
0.304 | ||
| ENC000229 | ![]() |
0.452 | D0N6CR | ![]() |
0.299 | ||
| ENC000303 | ![]() |
0.441 | D06LYG | ![]() |
0.286 | ||
| ENC000586 | ![]() |
0.429 | D0M1PQ | ![]() |
0.286 | ||
| ENC000302 | ![]() |
0.408 | D0Q7ZG | ![]() |
0.284 | ||
| ENC000176 | ![]() |
0.403 | D0B7OD | ![]() |
0.280 | ||
| ENC000300 | ![]() |
0.400 | D02YPG | ![]() |
0.277 | ||
| ENC000311 | ![]() |
0.400 | D0FN7J | ![]() |
0.275 | ||